Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S1B-509 for Weight Loss
NCT06517797Phase 2Not yet recruiting
- Sponsor
- S1 Biopharma
- Start
- Oct 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of S1B-509 in obesity, sponsored by S1 Biopharma. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
S1B-509
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06517797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06517797.